NCT00386529

Brief Summary

The purpose of this study is to evaluate the influence of aspirin on blood pressure in well-controlled hypertensive patients who receive low dose aspirin at different times of the day

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
191

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Sep 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2006

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 9, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 11, 2006

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2007

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
Last Updated

December 15, 2010

Status Verified

December 1, 2010

Enrollment Period

4 months

First QC Date

October 9, 2006

Last Update Submit

December 14, 2010

Conditions

Keywords

low dose aspirinHypertensionadministration time dependent effect

Outcome Measures

Primary Outcomes (1)

  • the changes in diastolic blood pressure

Secondary Outcomes (3)

  • the changes in systolic blood pressure

  • the trend in home blood pressure for medication

  • the comparison of the changes in systolic and diastolic pressure in dipper and non-dipper patients

Interventions

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age : 30 - 70 (inclusive)
  • Essential hypertension without complication
  • Well-controlled blood pressure over 3 months with same antihypertensive medication without changes in dose and frequency
  • Averages of two consecutive sitting diastolic and systolic blood pressures are \<90 mmHg and \<140 mmHg, respectively at screening and visit 1
  • Differences in sitting diastolic and systolic blood pressures between screening and visit 1 are 10 mmHg and 20 mmHg, respectively.
  • Willing and able to give informed consent

You may not qualify if:

  • patients with sitting diastolic blood pressure \< 70 mmHg
  • patients with secondary or malignant hypertension
  • patients with complication or high risk of complication
  • proven coronary artery or peripheral vascular diseases
  • Framingham CHD Risk Score (10 years) 20
  • Fasting blood glucose 110 mg/dl
  • Hyperlipidemia under treatment or treatment required
  • patients with myocardial infarction or severe cerebrovascular disorder in last 6 months
  • patients with chronic renal insufficiency
  • patients with unstable angina
  • patients with severe left ventricular abnormalities or valvular defect
  • patients with bradycardia(pulse rate \< 50 times/min) or chronic tachycardia (pulse rate 100 times/min), second degree AV-block
  • SGOT, SGPT\> 2.5 times upper limit range or serum creatinine \> 1.5 times upper limit range
  • patients with unresolved malignant tumor or systemic infection
  • lactating or pregnant females or females of childbearing potential who do not undergo hysterectomy or are not willing to use "effective" method of contraception.
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyungpook National University Hospital

Daegu, 700-721, South Korea

Location

Related Publications (5)

  • Avanzini F, Palumbo G, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, Capra A, Rossi S, Nosotti L, Costantini C, Pietrofeso R. Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study. Am J Hypertens. 2000 Jun;13(6 Pt 1):611-6. doi: 10.1016/s0895-7061(00)00231-4.

  • Magen E, Viskoper JR, Mishal J, Priluk R, London D, Yosefy C. Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects. J Hum Hypertens. 2005 Sep;19(9):667-73. doi: 10.1038/sj.jhh.1001910.

  • Hermida RC, Fernandez JR, Ayala DE, Mojon A, Iglesias M. Influence of aspirin usage on blood pressure: dose and administration-time dependencies. Chronobiol Int. 1997 Nov;14(6):619-37. doi: 10.3109/07420529709001452.

  • Hermida RC, Ayala DE, Iglesias M. Administration time-dependent influence of aspirin on blood pressure in pregnant women. Hypertension. 2003 Mar;41(3 Pt 2):651-6. doi: 10.1161/01.HYP.0000047876.63997.EE. Epub 2002 Dec 9.

  • Hypertension 2005;46[part2]:1060-1068

    RESULT

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Shung Chull Chae, Professor

    Kyungpook National University Hospital

    STUDY CHAIR
  • Dong Ju Choi, Professor

    Seoul National University Bundang Hospital

    PRINCIPAL INVESTIGATOR
  • Dong Su Kim, Professor

    Inje University

    PRINCIPAL INVESTIGATOR
  • Jeong Bae Park, Professor

    Cheil General Hospital and Women's Healthcare Center

    PRINCIPAL INVESTIGATOR
  • Nam Sik Chung, Professor

    Severance Hospital

    PRINCIPAL INVESTIGATOR
  • Sang Hong Baek, Professor

    The Catholic University of Korea

    PRINCIPAL INVESTIGATOR
  • Chang Wook Nam, Professor

    Keimyung University Dongsan Medical Center

    PRINCIPAL INVESTIGATOR
  • Young Jo Kim, Professor

    Yeungnam University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 9, 2006

First Posted

October 11, 2006

Study Start

September 1, 2006

Primary Completion

January 1, 2007

Study Completion

August 1, 2008

Last Updated

December 15, 2010

Record last verified: 2010-12

Locations